Role of a Subdominant H-2Kd-Restricted SV40 Tumor Antigen Cytotoxic T Lymphocyte Epitope in Tumor Rejection

This publication has 40 references indexed in Scilit:

• Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In Vivo
  Annual Review of Immunology, 1996
• Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules
  Immunity, 1995
• Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
  The Journal of Experimental Medicine, 1994
• Presentation of numerous viral peptides to mouse major histocompatibility complex (MHC) class I-restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter.
  The Journal of Experimental Medicine, 1993
• Peptides Naturally Presented by MHC Class I Molecules
  Annual Review of Immunology, 1993
• Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells
  Clinical and Experimental Immunology, 1993
• Immune control of SV40‐induced tumors in mice
  International Journal of Cancer, 1987
• SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice
  Nature, 1985
• Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens
  Nature, 1976
• Acquisition of Malignant Properties by SV40-Transformed Mouse Cells: Relationship to Type-C Viral Antigen Expression
  Intervirology, 1974